OTC Markets OTCPK - Delayed Quote USD

NEXT-ChemX Corporation (CHMX)

5.16
+0.02
+(0.39%)
As of June 8 at 8:00:00 PM EDT. Market Open.
Loading Chart for CHMX
  • Previous Close 5.14
  • Open 5.16
  • Bid 4.90 x 14200
  • Ask 5.20 x 70000
  • Day's Range 5.16 - 5.16
  • 52 Week Range 1.90 - 5.16
  • Volume 110
  • Avg. Volume 322
  • Market Cap (intraday) 147.301M
  • Beta (5Y Monthly) -0.10
  • PE Ratio (TTM) --
  • EPS (TTM) -0.06
  • Earnings Date Aug 18, 2025 - Aug 22, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

NEXT-ChemX Corporation owns a novel proprietary ion targeting membrane extraction technology that mimics biophysical processes enabling the technology to extract ions from a liquid solution and extract them into concentrated form. Its technology is designated as NCX and applied for lithium extraction, vegetable oil refining, radioactive ion extraction, metal ions extraction, and desalination. The company was formerly known as AllyMe Group, Inc. and changed its name to NEXT-ChemX Corporation in July 2021. NEXT-ChemX Corporation was incorporated in 2014 and is headquartered in Las Vegas, Nevada. NEXT-ChemX Corporation is a subsidiary of NEXT-ChemX Texas.

www.next-chemx.com

5

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CHMX

View More

Performance Overview: CHMX

Trailing total returns as of 6/10/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CHMX
31.97%
S&P 500 (^GSPC)
2.44%

1-Year Return

CHMX
134.55%
S&P 500 (^GSPC)
12.39%

3-Year Return

CHMX
58.72%
S&P 500 (^GSPC)
54.45%

5-Year Return

CHMX
22.86%
S&P 500 (^GSPC)
88.86%

Compare To: CHMX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CHMX

View More

Valuation Measures

Annual
As of 6/9/2025
  • Market Cap

    147.30M

  • Enterprise Value

    149.83M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -31.09%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -1.72M

  • Diluted EPS (ttm)

    -0.06

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    612

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -767.81k

Research Analysis: CHMX

View More

Company Insights: CHMX

Research Reports: CHMX

View More

People Also Watch